NEWS CENTER

On June 7th, the US FDA announced approval for Bojian/Weicai Company Aβ (β Amyloid protein) antibody Aduhelm (aducanumab) Application for Biological Product License (BLA) for the treatment of early Alzheimer's disease (AD) patients. Aducanumab is a new drug approved by the FDA for the treatment of Alzheimer's disease since 2003 Alzheimer's di...

On August 8, 2021, Rongchang Biotechnology (09995. HK) reached a global exclusive licensing agreement with internationally renowned biopharmaceutical company Seagen Inc. (SGEN) to develop and commercialize its ADC new drug, vidiximab. It is reported that Rongchang Biotechnology will generate a total potential revenue of up to 2.6 billion US ...

Waltham, Massachusetts - (BUSINESS WIRE) -; (American business information) -- PerkinElmer (New York Stock Exchange code: PKI) (“ PerkinElmer”) announced today that it has reached an agreement to acquire BioLegend, a global provider of life science antibodies and reagents, with a cash and stock portfolio of about 5.25 billion dollar...

Cyclic peptides help cancer cells proliferate. Cyclic peptides help cancer cells proliferate. Cyclic peptides help cancer cells proliferate. Cyclic peptides help cancer cells proliferate. Cyclic peptides help cancer cells proliferate. Cyclic peptides help cancer cells proliferate. Cyclic peptides help cancer cells proliferate. Cyclic peptides help ...

On August 5th, the official website of the National Drug Administration (NMPA) of China announced that the anti PD-1 antibody drug, Paprilimab (AK105), jointly declared by Kangfang Biotechnology and Zhengda Tianqing, has been approved. According to the public information, the approved indications of paclitaxel monoclonal antibody this time are: for...